Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
163
-
Total 13F shares, excl. options
-
82M
-
Shares change
-
+2.63M
-
Total reported value, excl. options
-
$1.66B
-
Value change
-
+$54.5M
-
Put/Call ratio
-
0.59
-
Number of buys
-
75
-
Number of sells
-
-80
-
Price
-
$20.20
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q1 2021
191 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q1 2021.
Evolent Health, Inc. - Class A Common Stock (EVH) has 163 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82M shares
of 112M outstanding shares and own 73.42% of the company stock.
Largest 10 shareholders include Engaged Capital LLC (8.55M shares), VANGUARD GROUP INC (7.32M shares), JPMORGAN CHASE & CO (6.97M shares), BlackRock Inc. (5.91M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (4.72M shares), CREDIT SUISSE AG/ (4.16M shares), Bellevue Group AG (3.53M shares), DIMENSIONAL FUND ADVISORS LP (3.45M shares), EAGLE ASSET MANAGEMENT INC (3.38M shares), and BLAIR WILLIAM & CO/IL (2.39M shares).
This table shows the top 163 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.